Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Fig. 3

Gut microbial profiles in lung cancer patients with impaired pulmonary function. (A) α-diversity based on the Ace, Chao, Shannon, Simpson and Sobs indices. *P < 0.05. (B) Partial Least Squares Discriminant Analysis (PLS-DA) analysis between ZC, QD and ZZD patients. ZC, Normal pulmonary function; QD, Mild pulmonary ventilation dysfunction; ZZD, Moderate or above pulmonary ventilation dysfunction

Back to article page